GPCR News 

Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...

Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5

Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors

Dimerization of β2-adrenergic receptor is responsible for the constitutive activity subjected to inv

Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..

Structural basis of adhesion GPCR GPR110 activation by stalk peptide and G-proteins coupling

GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...

Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of...

Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and...

Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner

Amgen to Acquire Chemocentryx for $4 Billion in Cash

Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...

Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update

Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares

Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...

SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...

Trevena Reports Second Quarter 2022 Results and Provides Business Update

G.CLIPS biotech is 2 years old this month!

Exscientia is 10 years old this July!

X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE